CCDC85C Activators
CCDC85C activators are a chemically varied group of molecules known for their role in modulating the function of the protein known as Coiled-coil domain-containing protein 85C (CCDC85C). This group of compounds operates through diverse biochemical pathways, but they converge on a common endpoint: the modulation of CCDC85C activity. The primary mechanism through which these activators exert their influence is by affecting the intracellular levels of cyclic adenosine monophosphate (cAMP), a critical secondary messenger within cellular signaling pathways. Compounds like forskolin, directly stimulate adenylyl cyclase, the enzyme responsible for the synthesis of cAMP from ATP, thus leading to an increase in the levels of this messenger molecule. Elevated cAMP, in turn, activates protein kinase A (PKA), which plays a pivotal role in the phosphorylation of various proteins within the cell.
Other activators, such as IBMX (Isobutylmethylxanthine) and caffeine, function as phosphodiesterase inhibitors, thereby preventing the degradation of cAMP and contributing to its accumulation within the cellular environment. This increase in cAMP levels results in a sustained activation of PKA. The PKA enzyme then engages in the phosphorylation of target proteins, which may include CCDC85C, although the exact proteins subject to phosphorylation can vary depending on the cell type and context. In addition to these, adrenergic agonists such as epinephrine and isoproterenol enhance cAMP levels by binding to their respective receptors on the cell surface. This receptor-mediated pathway also leads to the activation of adenylyl cyclase and a subsequent rise in cAMP. Similarly, glucagon, acting through its cognate receptor, contributes to the same outcome.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing the breakdown of cAMP. The sustained levels of cAMP can enhance PKA activity, which in turn, could enhance the functional activity of Coiled-coil domain-containing protein 85C by phosphorylation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, stimulating the production of cAMP via adenylyl cyclase activation, which then activates PKA. PKA can influence the function of Coiled-coil domain-containing protein 85C through phosphorylation. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G protein-coupled receptors, elevating cAMP levels, hence activating PKA. PKA could enhance the activity of Coiled-coil domain-containing protein 85C through phosphorylation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram selectively inhibits phosphodiesterase 4, increasing intracellular cAMP levels, which in turn activates PKA. PKA could then enhance the activity of Coiled-coil domain-containing protein 85C. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine is a phosphodiesterase inhibitor, which leads to an increase in cAMP levels, activating PKA. PKA could then phosphorylate and enhance the functional activity of Coiled-coil domain-containing protein 85C. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is an agonist at beta-adrenergic receptors, increasing cAMP production, and subsequently activating PKA. This activation can enhance the phosphorylation state and functional activity of Coiled-coil domain-containing protein 85C. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol activates beta-2 adrenergic receptors, which increases cAMP levels and activates PKA. PKA may enhance the phosphorylation and activity of Coiled-coil domain-containing protein 85C. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide inhibits phosphodiesterase III, resulting in increased cAMP levels and PKA activation. PKA, in turn, could enhance the activity of Coiled-coil domain-containing protein 85C through phosphorylation. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline, a beta-2 adrenergic receptor agonist, raises cAMP levels, thereby activating PKA. This could lead to enhanced phosphorylation and activity of Coiled-coil domain-containing protein 85C. | ||||||